Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
1.650
-0.190 (-10.33%)
Dec 20, 2024, 4:00 PM EST - Market closed
Envoy Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -21.06 | -29.91 | -15.92 | -8.68 |
| Depreciation & Amortization | 0.17 | 0.13 | 0.08 | 0.07 |
| Loss (Gain) From Sale of Assets | - | - | - | 0 |
| Stock-Based Compensation | 1.98 | 1.58 | - | - |
| Other Operating Activities | -0.07 | 11.5 | 7.2 | 1.75 |
| Change in Accounts Receivable | -0.09 | -0.03 | 0.05 | -0.02 |
| Change in Inventory | -0.15 | -0.01 | -0.19 | 0.06 |
| Change in Accounts Payable | -1.62 | 0.55 | 0.34 | 0.23 |
| Change in Other Net Operating Assets | -4.44 | -1.47 | -0.36 | -0.35 |
| Operating Cash Flow | -25.27 | -17.65 | -8.81 | -6.94 |
| Capital Expenditures | -1.54 | -0.15 | -0.22 | -0.13 |
| Investing Cash Flow | -1.54 | -0.15 | -0.22 | -0.13 |
| Long-Term Debt Issued | - | 10 | 8 | 8 |
| Net Debt Issued (Repaid) | 15 | 10 | 8 | 8 |
| Issuance of Common Stock | 2.23 | 0.11 | - | - |
| Other Financing Activities | - | 11.74 | 0.09 | 0.06 |
| Financing Cash Flow | 14.39 | 21.85 | 8.09 | 8.06 |
| Foreign Exchange Rate Adjustments | -0.01 | -0 | -0.01 | -0.01 |
| Net Cash Flow | -12.42 | 4.04 | -0.94 | 0.99 |
| Free Cash Flow | -26.8 | -17.81 | -9.02 | -7.06 |
| Free Cash Flow Margin | -9641.73% | -5635.13% | -3807.17% | -2277.74% |
| Free Cash Flow Per Share | -1.36 | -1.42 | -0.89 | -0.70 |
| Levered Free Cash Flow | -6.57 | -6.54 | -5.17 | - |
| Unlevered Free Cash Flow | -6.3 | -6.54 | -5.17 | - |
| Change in Net Working Capital | -6.5 | -3.39 | -0.41 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.